Exact Sciences Price/Book Ratio 2010-2024 | EXAS

  • Exact Sciences average price/book ratio for 2024 was 3.69, a 16.89% decline from 2023.
  • Exact Sciences average price/book ratio for 2023 was 4.44, a 66.29% decline from 2022.
  • Exact Sciences average price/book ratio for 2022 was 2.67, a 48.95% increase from 2021.

Price/book ratio can be defined as

Historical Chart (TTM)

Click on chart icon to view chart
Click on table icon to view table

Annual Chart

Click on chart icon to view chart
Click on table icon to view table
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$228.9B
Amgen (AMGN)$158.1B
Gilead Sciences (GILD)$134.2B
Vertex Pharmaceuticals (VRTX)$121.1B
Bristol Myers Squibb (BMY)$111.6B
CSL (CSLLY)$80.7B
GSK (GSK)$75.7B
Regeneron Pharmaceuticals (REGN)$75B
Argenex SE (ARGX)$38.9B
Alnylam Pharmaceuticals (ALNY)$32.4B
BioNTech SE (BNTX)$28.7B
BeiGene (ONC)$23.2B
Biogen (BIIB)$20B
Illumina (ILMN)$16.3B
Insmed (INSM)$15B
Genmab (GMAB)$14.5B
Genmab (GNMSF)$14.4B
Moderna (MRNA)$13.8B
Intra-Cellular Therapies (ITCI)$13.7B
Incyte (INCY)$13.6B
BioMarin Pharmaceutical (BMRN)$12.5B
Swedish Orphan Biovitrum (BIOVF)$10.9B
Bio-Techne Corp (TECH)$10.4B
Vaxcyte (PCVX)$10.4B
Sarepta Therapeutics (SRPT)$10.2B
Exelixis (EXEL)$9.8B
Ascendis Pharma (ASND)$9.4B
Bio-Rad Laboratories (BIO.B)$8.7B
QIAGEN (QGEN)$8.7B
Repligen (RGEN)$8.4B